Here’s another recipient of Frost & Sullivan’s 2006 Awards. This one is in the field of cardiac diagnostics, awarded to Inovise Medical, Inc. for “its development of the breakthrough AUDICOR Correlated Audioelectric Cardiography (COR) technology. This non-invasive cardiac system aids higher risk cardiac patients across continuum of care; prehospital, Emergency Department (ED), inpatient, physician office and home use.”
Technology developed by the company merges EKG and cardiac auscultation to document the presence of S3 heart sound. According to the company, its technology has a high specificity (95%) of S3 detection, which in turn allows “physicians and nurses to accurately rule-in heart failure in patients over age 40 who present with dyspnea helping to reduce the prevailing missed diagnosis rate for heart failure.”
From Inovise Medical’s website:
AUDICOR® simultaneously evaluates the electrical and acoustical activities of the heart to detect, accurately interpret, and clearly document the presence of the third heart sound (S3) by using the company’s patented Correlated Audioelectric Cardiography (COR) technology. Unlike other cardiac diagnostic technologies that focus on either the electrical or the mechanical capabilities of the heart, AUDICOR® analyzes the entire function of the heart concurrently and provides clinicians a complete analysis of the heart’s hemodynamic capabilities. AUDICOR® is currently demonstrating clinical utility by facilitating the assessment of left ventricular dysfunction, filling patterns and pressures, low ejection fractions, and monitoring changes in cardiac dysynchrony as a result of therapy.
Company’s technology comes in the following configurations:
— as an add-on unit to existing ECG technology (AUDIOCOR CE®)
— as a stand-alone unit (AUDICOR® 200)
— as an embedded technology in cardiovascular equipment.